Nov 03 2020: The global Spine Biologics market was valued at $XX million in 2018, and Radiant Research analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028.
This report provides detailed historical analysis of global market for Spine Biologics from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Spine Biologics market.
To Request A Sample Copy Of This Report @: https://www.radiantinsights.com/research/2013-2028-report-on-global-spine-biologics-market/request-sample
Leading players of Spine Biologics including:
- Medtronic
- Depuy Synthes
- Stryker Corporation
- Nuvasive
- Zimmer Biomet
- Orthofix International
- Globus Medical
- alphatec spine
- K2M
- Exactech
- Wright Medical Technology
- X-Spine
- Nutech
- Arthrex
Market split by Type, can be divided into:
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- BMAC (Bone Marrow Aspirate Concentrate)
Market split by Application, can be divided into:
- Anterior Cervical Discectomy and Fusion
- Posterior Lumbar Interbody Fusion
- Other
Market split by Sales Channel, can be divided into:
- Direct Channel
- Distribution Channel
Market segment by Region/Country including:
- North America (United States, Canada and Mexico)
- Europe (Germany, UK, France, Italy, Russia and Spain etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
- South America Brazil, Argentina, Colombia and Chile etc.)
- Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
To Browse Full Research Report @:
https://www.radiantinsights.com/research/2013-2028-report-on-global-spine-biologics-market
Table of Contents
Chapter 1 Spine Biologics Market Overview
1.1 Spine Biologics Definition
1.2 Global Spine Biologics Market Size Status and Outlook (2013-2028)
1.3 Global Spine Biologics Market Size Comparison by Region (2013-2028)
1.4 Global Spine Biologics Market Size Comparison by Type (2013-2028)
1.5 Global Spine Biologics Market Size Comparison by Application (2013-2028)
1.6 Global Spine Biologics Market Size Comparison by Sales Channel (2013-2028)
1.7 Spine Biologics Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Spine Biologics Market Segment Analysis by Player
2.1 Global Spine Biologics Sales and Market Share by Player (2016-2018)
2.2 Global Spine Biologics Revenue and Market Share by Player (2016-2018)
2.3 Global Spine Biologics Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Spine Biologics Market Segment Analysis by Type
3.1 Global Spine Biologics Market by Type
3.1.1 Bone Graft
3.1.2 Bone Graft Substitute
3.1.3 Platelet Rich Plasma (PRP)
3.1.4 BMAC (Bone Marrow Aspirate Concentrate)
3.2 Global Spine Biologics Sales and Market Share by Type (2013-2018)
3.3 Global Spine Biologics Revenue and Market Share by Type (2013-2018)
3.4 Global Spine Biologics Average Price by Type (2013-2018)
3.5 Leading Players of Spine Biologics by Type in 2018
3.6 Conclusion of Segment by Type
Continued…………….
To See More Reports of This Category by Radiant Insights:
https://latestmarkettrends.news.blog/
About Radiant Insights:
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: [email protected]
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
https://marketsandtrendsreport.blogspot.com/
Biologics have been an increasingly important component to be used in spinal fusion surgery, due to the growing awareness about their potential impact, usage of bone graft substitutes, and the rising geriatric population.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=17444 Spine biologics are used in the treatment of spine trauma, tumors, and degenerative diseases in order to achieve arthrodesis in case of deformity or instability.
The favored usage of biologics among surgeons, the minimal pain and invasiveness they cause, and the rise in obesity as well as geriatric population are drivers of the global spine biologics market.
Based on type of surgery, the divisions are anterior cervical discectomy and fusion (ACDF), anterior lumbar interbody fusion (ALIF), lateral lumbar interbody fusion (LLIF), and transforaminal lumbar interbody fusion (TLIF).
RhBMP-2 approved by FDA in 2002 and marketed as infuse by Medtronic Sofamor Danek, Inc. is used for insertion within a titanium tapered cage in anterior lumbar interbody fusion surgery.
North America holds a major share in the market, followed by Europe, due to developed technologies and hospitals, rise in the citizens’ per capita income, and improved medical literacy.
